Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • STM vs GSK✓SelectedUSD · GSKSTM vs GSK performance historyLatest closeAs of-0.70%11/17
Stock and ETF performance explorer

STM vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+417.7%
GSK return
+103.9%
Excess return
+313.8%
Maximum drawdown
-66.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%-2.3%+1.6%+0.2%
7D-1.1%-3.0%+1.9%+0.1%
30D-2.6%+0.4%-2.9%-3.0%
3M-20.6%-1.2%-19.4%-21.0%
6M-27.8%+0.9%-28.7%-29.6%
YTD+71.4%+4.0%+67.5%+63.8%
1Y+96.2%+7.3%+88.9%+84.8%
3Y-0.3%+57.1%-57.4%-26.2%
5Y-10.4%+43.0%-53.4%-31.6%
All+417.7%+103.9%+313.8%+262.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling